FDA NDC Directory · JSON-LD · Markdown

INGREZZA

NDC 70370-2040 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameValbenazine
Labeler / ManufacturerNeurocrine Biosciences, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA209241
Dosage form / routeCAPSULE · ORAL
Active ingredientsVALBENAZINE TOSYLATE (40 mg/1)
Marketing started20181214
Package count1

External sources

Source: openFDA. Public-domain (CC0).